| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/07/2008 | US20080188543 {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid; deep vein thrombosis and coronary heart disease, Alzheimer's disease and pulmonary fibrosis |
| 08/07/2008 | US20080188480 Use of Sildenafil, Vardenafil and Other 5-Phosphodiesterase Inhibitors to Enhance Permeability of the Abnormal Blood-Brain Barrier |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080188400 Methods For Treating Bleeding |
| 08/07/2008 | US20080187622 Method for manufacturing alpha-glycosylisoquercitrin, intermediate product and by-product thereof |
| 08/07/2008 | US20080187602 Stabilized lanthanum carbonate compositions |
| 08/07/2008 | US20080187524 Treating an aneurysm via harvesting, propagating and delivering adult adipose, bone marrow and/or peripheral stem cells directly to wall of blood vessel at aneurysmal site; tissue engineering; regenerative medicine; tissue repair |
| 08/07/2008 | DE60223151T2 Chinazolinonderivat Quinazolinone derivative |
| 08/06/2008 | EP1953227A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 08/06/2008 | EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 08/06/2008 | EP1952812A1 Drug for treating thalessemia, falciform anemia and all other forms of anemia treatable therewith |
| 08/06/2008 | EP1951717A1 Novel pyrrolidine derivatives as inhibitors of coagulation factor xa |
| 08/06/2008 | EP1951712A2 Chemical compounds |
| 08/06/2008 | EP1951653A1 Salicylic acid derivatives |
| 08/06/2008 | EP1599258B1 Fumed silica embolic compositions |
| 08/06/2008 | EP1495051B1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1449920B1 Trangenic mice used as model for human pathologies originating from stem cells |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1236712B1 Amidinophenylpyruvic acid derivative |
| 08/06/2008 | CN101237879A 抗凝剂及其用途 Anticoagulants and their use |
| 08/06/2008 | CN101235367A Method for preparing ganoderma sinensis streptokinase and application thereof |
| 08/06/2008 | CN101235031A Oriented synthesis and crystal structure of 21(S) argatroban, and preparation for monohydrate thereof |
| 08/06/2008 | CN101234192A Activated plasma thromboplastin component VII for treating massive haemorrhage caused by thrombolysis therapy |
| 08/06/2008 | CN101234181A Medicament for preventing and treating leukopenia used in tumor radiotherapy and chemotherapy course |
| 08/06/2008 | CN101234175A Chinese medicine thrombolysis paralysis-treating granule for treating acute cerebral infarction |
| 08/06/2008 | CN101234172A Method of preparing Chinese medicine for treating qi-deficiency type metrorrhagia |
| 08/06/2008 | CN101234159A Pharmaceutical combination with synergistic reaction |
| 08/06/2008 | CN101234094A Dipyridamole orally disintegrating tablet and preparation |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408535C Preparation method of extracting hemostatic substance 1,3-dihydroxyanthraquinone from India madder charcoal |
| 08/06/2008 | CN100408099C Oral pharmaceutical composition containing a block copolymer |
| 08/06/2008 | CN100408066C Preparing process and product of Chinese medicine dripping pill with tea extract |
| 08/06/2008 | CN100408035C Use of valsartan or its metabolite to inhibit platelet aggregation |
| 08/05/2008 | US7408046 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders |
| 08/05/2008 | US7408039 Induction of chimera mixture; anticancer agents, leukemia |
| 08/05/2008 | US7408024 Somatostatin antagonists |
| 08/05/2008 | US7407982 Polyoxyethylene glycol conjugates mean the drug is eliminated almost completely through the kidneys; bioavailability; anticoagulants |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407945 Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407663 Modified immunodeficiency virus particles |
| 08/05/2008 | US7407475 Modified annexin proteins, and methods and compositions for using them |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2223595C Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 08/05/2008 | CA2176649C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090857A1 COMPOUND, α1 ADRENALINE RECEPTOR ANTAGONIST, AND COMPOSITION |
| 07/31/2008 | WO2008090331A1 Serotonin reuptake inhibitors for treating arthritis |
| 07/31/2008 | WO2008090291A1 Anti-oxidant dietary composition containing fruits and vegetables, method for preparing the same and use of the composition |
| 07/31/2008 | WO2008090224A1 Method for inducing thrombopoiesis |
| 07/31/2008 | WO2008089776A1 Formulation of and method for producing an infusion rehydration solution |
| 07/31/2008 | WO2008089669A1 A novel combination of epimedium-derived-flavonoids-fractions for prevention of steroid-induced osteonecrosis |
| 07/31/2008 | WO2007149283B1 Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080182976 kit for detecting erythropoietin receptors which is capable of being activated comprising an antibody or fragment which activates formation or production of erythrocytes; treatment of anemia |
| 07/31/2008 | US20080182887 atorvastatin, atorvastatin lactone less than 0.5% by weight of atorvastatin, and carrier comprising 0.5% - 3.0% by weight of tromethamine and an additional stabilizer (antioxident) to prevent degradation of atorvastatin; storage stability |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182806 Use of acetylated or esterificated azacytidine, decitabine, or other nucleoside analogs as oral agents for the treatment of tumors or other dysplastic syndromes sensitive to hypomethylating agents |
| 07/31/2008 | US20080182791 Medicament for Improving Prognostic Survival in Therapy of Malignant Tumor |
| 07/31/2008 | US20080182283 Inhibitors of human plasmin derived from the kunitz domains |
| 07/31/2008 | US20080181975 Vasoprotective agent |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181946 Controlled Release Delivery System For Metformin |
| 07/31/2008 | US20080181897 Which specifically bind to or interact with human G-CSF receptor and dimerize the receptor or activate phosphorylation of kinases associated with the receptor to stimulate cell proliferation and differentiation |
| 07/31/2008 | US20080181878 composition of thrombin and fibrinogen dimer selected from the group consisting of fibrinogen gamma A/ gamma ' heterodimer and fibrinogen gamma '/ gamma ' homodimer; trauma, plastic, dental, and general surgery, minimally invasive surgery, endoscopy, and microsurgery |
| 07/31/2008 | DE102007005329A1 Use of adenosine for erythrocytes protection, and for prevention of sepsis, hemolytic uremic syndrome, microcirculation disturbances, diabetic vascular disease or anemia, has antibiotic or cytostatic drug |
| 07/31/2008 | CA2676208A1 Compound, a1 adrenergic receptor antagonist agent, and composition |
| 07/30/2008 | EP1950299A1 Mammalian receptor proteins; related reagents and methods |
| 07/30/2008 | EP1950209A1 Agent for treatment of circulatory failure |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949890A2 Implantable gel compositions and method of manufacture |
| 07/30/2008 | EP1948690A2 Compositions and methods for modulating hemostasis |
| 07/30/2008 | EP1648924B1 Dipeptide transglutaminase inhibitors and methods of using the same |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | CN101233225A Strain of turkey tail mushroom, extract from the same, and use of the same |
| 07/30/2008 | CN101233108A Cyclic amine derivative having substituted alkyl group |
| 07/30/2008 | CN101233106A Thiomorpholine compound and process for preparing the same |
| 07/30/2008 | CN101230340A 纤维蛋白溶解活性多肽 Fibrinolytic activity of the polypeptide |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101229388A Stanching material (spray, membrane) based on Chinese herbal medicine and preparing method thereof |
| 07/30/2008 | CN101229369A Antiatheroscloresis thrombolytic soft capsule and preparing method thereof |
| 07/30/2008 | CN101229367A Process of preparing human fibrinogen preparation |
| 07/30/2008 | CN101229345A Qi-replenishing and blood-enriching medicine |
| 07/30/2008 | CN101229330A Bamboo shoot extract compound preparation and preparing method thereof |
| 07/30/2008 | CN101229312A Medicine compounds capable of regulating hypertension, hyperlipemia and angina |
| 07/30/2008 | CN101229248A Quality standard and test method of hoove pill and preparation threrewith |
| 07/30/2008 | CN101229205A Hemlock parsley oil self-emulsifiable oral medicine delivery system and preparing method thereof |
| 07/30/2008 | CN100406558C Method for preparing recombinant aprotinin |
| 07/30/2008 | CN100406554C Colibacillus containing human source guide suppository dissolving antibody gene and its secretion producg |
| 07/30/2008 | CN100406468C Design of antisuppository KGD-cyclohepta-peptide, its preparation and use thereof |